Source: Eur Respir J 2002; 19: 1119-1123
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Beeh K.M., Beier J., Haas I.C., Kornmann O., Micke P., Buhl R.. Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis. Eur Respir J 2002; 19: 1119-1123

Member's Comments

No comment yet.

Related content which might interest you: Induced sputum glutathione levels are decreased in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 409s Year: 2001 Glutathione and glutamate levels in the diaphragm of patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 23: 545-551 Year: 2004 Oxidation contributes to low glutathione in the airways of children with cystic fibrosis Source: Eur Respir J 2014; 44: 122-129 Year: 2014 Increased levels of oxidative stress markers in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Influence of smoking history on activity of extra cellular glutathione peroxidase and catalase in induced sputum in patients with chronic obstructive pulmonary disease, asthma and healthy volunteers Source: Eur Respir J 2005; 26: Suppl. 49, 344s Year: 2005 Serum levels of surfactant proteins in patients with combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2015 – IPF pathogenesis Year: 2015 Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 39: 359-365 Year: 2012 Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients Source: Eur Respir J 2009; 33: 1309-1319 Year: 2009 Serum surfactant protein D may predict the effect of pirfenidone in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Lysozyme level and activity are decreased in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and potentially contribute to increased susceptibility to pulmonary infection Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases Year: 2006 Coexistent pulmonary emphysema delays the decrease in vital capacity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 COPD is associated with reduced pulmonary interstitial expression of pentraxin-3 Source: Eur Respir J 2012; 39: 830-838 Year: 2012 Induced sputum and respiratory function in pulmonary fybrosis Source: Eur Respir J 2003; 22: Suppl. 45, 178s Year: 2003 Serum surfactant protein D (SP-D) and annual decline of diffusion capacity are prognostic factors for combined pulmonary fibrosis with emphysema (CPFE) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013 17(R)-resolvinD1 improves MMP-9/TIMP-1 imbalance leading to amelioration of pulmonary fibrosis in mice Source: International Congress 2016 – ILD pathogenesis Year: 2016 Pulmonary function of infants with cystic fibrosis, with and without respiratory symptoms Source: Eur Respir J 2002; 20: Suppl. 38, 529s Year: 2002 Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis Source: Eur Respir J 2002; 19: 439-446 Year: 2002 Does interferon-γ improve pulmonary function in idiopathic pulmonary fibrosis? Source: Eur Respir J 2003 Dec 01;22(6):906-911 Year: 2003 High mobility group box protein 1 (HMGB1) production in highly vascularized alveolar lesions causes acute exacerbation in idiopathic pulmonary fibrosis Source: Annual Congress 2005 - Progresses in lung fibrosis Year: 2005